OBJECTIVE: To compare the association of obesity and abdominal obesity with cardiometabolic risk factor burden and global estimated coronary heart disease (CHD) risk among multiethnic US adults. DESIGN: Cross-sectional, survey study. SUBJECTS: A total of 4456 participants (representing 194.9 million adults) aged 20-79 years in the 2003-2004 National Health and Nutrition Examination Survey (NHANES). MEASUREMENTS: Body mass index (BMI) and waist circumference (WC) measures, CHD risk factors and a 10-year estimated CHD risk based on Framingham algorithms. Obesity was defined as a BMI >or=30 kg/m(2) and abdominal obesity as a WC >88 cm in women and >102 cm in men. High CHD risk status included diabetes, cardiovascular disease (CVD) or a 10-year Framingham risk score of >20%. RESULTS: Overall, abdominal obesity was present in 42.3% of men and 62.5% of women and in 53.6% of whites, 56.9% of blacks and 50.5% of Hispanics (P<0.001 between gender and ethnicity). However, using International Diabetes Federation (IDF)-recommended WC cut points for Hispanics, the prevalence of abdominal obesity was 78.3%. Mean levels of low-density lipoprotein cholesterol (LDL-C), systolic and diastolic blood pressure, fasting glucose and C-reactive protein increased, and high-density lipoprotein cholesterol (HDL-C) decreased (P<0.001) according to BMI and WC categories, although these associations were attenuated in blacks for blood pressure, LDL-C, HDL-C and triglycerides. Of those with high WC, 25-35% had >or=3 cardiometabolic risk factors. High CHD risk among those with high WC was most common in men (27.9%) and non-Hispanic whites (23.9%). Persons with a high vs normal WC, adjusted for age, gender, ethnicity and BMI were more likely to have >or=3 cardiometabolic risk factors (odds ratio (OR)=5.1, 95% confidence interval (CI)=3.9-6.6) and were classified as high CHD risk (OR=1.5, 95% CI=1.1-2.0). CONCLUSION: The association of abdominal obesity with risk factors varies by ethnicity and is independently associated with high CHD risk status, further validating its clinical significance.
OBJECTIVE: To compare the association of obesity and abdominal obesity with cardiometabolic risk factor burden and global estimated coronary heart disease (CHD) risk among multiethnic US adults. DESIGN: Cross-sectional, survey study. SUBJECTS: A total of 4456 participants (representing 194.9 million adults) aged 20-79 years in the 2003-2004 National Health and Nutrition Examination Survey (NHANES). MEASUREMENTS: Body mass index (BMI) and waist circumference (WC) measures, CHD risk factors and a 10-year estimated CHD risk based on Framingham algorithms. Obesity was defined as a BMI >or=30 kg/m(2) and abdominal obesity as a WC >88 cm in women and >102 cm in men. High CHD risk status included diabetes, cardiovascular disease (CVD) or a 10-year Framingham risk score of >20%. RESULTS: Overall, abdominal obesity was present in 42.3% of men and 62.5% of women and in 53.6% of whites, 56.9% of blacks and 50.5% of Hispanics (P<0.001 between gender and ethnicity). However, using International Diabetes Federation (IDF)-recommended WC cut points for Hispanics, the prevalence of abdominal obesity was 78.3%. Mean levels of low-density lipoprotein cholesterol (LDL-C), systolic and diastolic blood pressure, fasting glucose and C-reactive protein increased, and high-density lipoprotein cholesterol (HDL-C) decreased (P<0.001) according to BMI and WC categories, although these associations were attenuated in blacks for blood pressure, LDL-C, HDL-C and triglycerides. Of those with high WC, 25-35% had >or=3 cardiometabolic risk factors. High CHD risk among those with high WC was most common in men (27.9%) and non-Hispanic whites (23.9%). Persons with a high vs normal WC, adjusted for age, gender, ethnicity and BMI were more likely to have >or=3 cardiometabolic risk factors (odds ratio (OR)=5.1, 95% confidence interval (CI)=3.9-6.6) and were classified as high CHD risk (OR=1.5, 95% CI=1.1-2.0). CONCLUSION: The association of abdominal obesity with risk factors varies by ethnicity and is independently associated with high CHD risk status, further validating its clinical significance.
Authors: Cristina Palacios; Cynthia M Pérez; Manuel Guzmán; Ana P Ortiz; Alelí Ayala; Erick Suárez Journal: Public Health Nutr Date: 2011-05-24 Impact factor: 4.022
Authors: Daniela Catalano; Guglielmo M Trovato; Giuseppe Fabio Martines; Clara Pirri; Francesca M Trovato Journal: Hepatol Int Date: 2011-01-28 Impact factor: 6.047
Authors: Holly Kramer; Orlando M Gutiérrez; Suzanne E Judd; Paul Muntner; David G Warnock; Rikki M Tanner; Bhupesh Panwar; David A Shoham; William McClellan Journal: Am J Kidney Dis Date: 2015-07-15 Impact factor: 8.860
Authors: Marie-Ludivine Chateau-Degat; Eric Dewailly; Rabia Louchini; Emilie Counil; Martin Noël; Annie Ferland; Michel Lucas; Béatriz Valera; Jean-Marie Ekoé; Robert Ladouceur; S Déry; Grace Egeland Journal: Can J Cardiol Date: 2010 Jun-Jul Impact factor: 5.223
Authors: Alok K Gupta; Germaine Cornelissen; Frank L Greenway; Vijay Dhoopati; Franz Halberg; William D Johnson Journal: Cardiovasc Diabetol Date: 2010-09-24 Impact factor: 9.951
Authors: Dalia Stern; Nicole Middaugh; Megan S Rice; Francine Laden; Ruy López-Ridaura; Bernard Rosner; Walter Willett; Martin Lajous Journal: Am J Public Health Date: 2017-09-21 Impact factor: 9.308
Authors: Mariellen J Moore; Yan Gong; Wei Hou; Karen Hall; Siegfried O F Schmidt; Robert Whitney Curry; Amber L Beitelshees; Arlene Chapman; Stephen T Turner; Gary L Schwartz; Kent Bailey; Eric Boerwinkle; John G Gums; Rhonda M Cooper-DeHoff; Julie A Johnson Journal: Pharmacotherapy Date: 2014-09-09 Impact factor: 4.705